Influenza Diagnostics Market Size, Industry Analysis, Growth Factors

Posted by vinit sawant on April 6th, 2021

Market Highlights

As per the National Center for Biotechnology Information (NCBI) Report 2015, the influenza virus is responsible for seasonal epidemics affecting over 200,000 people with a death toll of approximately 30,000 to 50,000 patients every year in the US.

As per the World Health Organization Report (WHO) 2017, influenza virus-infected 5% to 15% of the global population. As the prevalence of influenza is increasing, the number of diagnostic techniques such as immunochromatography-based rapid diagnostic test (RDT) and nucleic acid amplification test (NAAT) are used for the detection of influenza viruses in humans.

The Influenza Diagnostics Market size is estimated to be valued at USD 954.512 million by 2023 and is expected to register a CAGR of 7.80% during the forecast period 2018-2023

Segment Analysis

The global influenza diagnostics market is segmented into type of flu, test type, and end user. On the basis of type of flu, the global influenza diagnostics market is further sub-segmented as type A flu, type B flu, and type C flu. The type A flu accounted for the market value of USD 286.401 million in 2017.

By test type, the global influenza diagnostics market has been sub-segmented into traditional diagnostic tests and molecular diagnostic tests. The test type segment accounted for the larger market share in 2017. However, the type of flu segment is expected to exhibit higher CAGR during the forecast period. Based on end user, the global influenza diagnostics market has been sub-segmented into hospitals & clinical laboratories and point-of-care testing.

Key Findings of the Study:

• Global influenza diagnostics market is projected to reach over USD 954.512 million by 2023 with 7.80% CAGR during the review period of 2018 to 2023
• The Middle East and Africa holds the lowest share in the global influenza diagnostics market due to low development, lack of technical knowledge, and poor medical facilities.
• Based on type of flu the type A flu segment holds the largest market value of USD 286.401 million in 2017.

Some of the players operating in the global influenza diagnostics market are Abbott, Analytik Jena AG, Becton, Dickinson and Company, Biocartis, bioMérieux Inc, Cepheid, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, GenMark Diagnostics, Inc., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, SA Scientific, Thermo Fisher Scientific Inc.